Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio to Provide Analysis Software to Customers of Microsynth's Sequencing Service


By Julia Karow

This article, originally published May 5, has been updated with additional information from Microsynth.

CLC Bio will provide high-throughput sequencing customers of Swiss molecular biology service provider Microsynth with a license to its analysis software, the company said last week.

Under the agreement, Microsynth, based in Balgach, Switzerland, will provide all customers receiving high-throughput sequencing data with a license to the Danish bioinformatics company's CLC Genomics Workbench software.

According to Christof Wunderlin, head of next-generation sequencing at Microsynth, his firm considered several software vendors and chose CLC Bio because of the variety of analyses it enables and data formats it supports, user-friendliness, relatively low hardware requirement, and price.

Partnering with a software provider became necessary because "many customers do not yet have experience with this kind of data and therefore no software in use," he told In Sequence.

Microsynth has been offering sequencing services on the 454 Genome Sequencer FLX platform since early 2008, and Sanger sequencing since 1992. The company uses Roche's software to provide primary data analysis, such as a draft assembly, for the 454 platform, but there comes a point when customers have to analyze the data on their own, Wunderlin said. Roche's GS Assembler, GS Mapper, and GS Amplicon Variant Analyzer are "excellent software," he added, but don't cover more downstream analyses.

According to its website, Microsynth offers a variety of services on the 454 Genome Sequencer FLX platform, including whole-genome sequencing, BAC sequencing, cDNA sequencing, amplicon sequencing, and metagenomics.

The company also offers Illumina sequencing services through a collaboration with Swiss service provider Fasteris, which is "especially interesting for hybrid approaches," Wunderlin said.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.